Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

28.00 -0.01 (-0.02%)
Streaming Delayed Price Updated: 1:27 PM EDT, Sep 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 439,410
Open 27.90
Bid (Size) 28.00 (500)
Ask (Size) 28.01 (400)
Prev. Close 28.01
Today's Range 27.85 - 28.10
52wk Range 27.23 - 37.78
Shares Outstanding N/A
Dividend Yield 3.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds
Smith+Nephew announces results of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030 
From Smith & Nephew Plc
Via ACCESS Newswire
News headline image
Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds
Smith+Nephew announces pricing of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030 
From Smith & Nephew Plc
Via ACCESS Newswire

Performance

YTD
-14.8%
-14.8%
1 Month
-5.6%
-5.6%
3 Month
-8.2%
-8.2%
6 Month
-16.1%
-16.1%
1 Year
-25.1%
-25.1%

More News

Read More
News headline image
Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m
From Smith & Nephew Plc
Via ACCESS Newswire
Smith & Nephew (NYSE:SNN) Looks Undervalued on Decent Value Screen ↗
Via Chartmill
News headline image
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith & Nephew plc (NYSE:SNN) Caviar Cruise Screen Analysis ↗
Via Chartmill
Smith & Nephew (NYSE:SNN) Qualifies as a Quality Investment Through the Caviar Cruise Screen ↗
Via Chartmill
Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing ↗
Via Chartmill
News headline image
Smith & Nephew SNATS Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings World Trade
News headline image
Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Economy World Trade
News headline image
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
From Equity Insider
Via GlobeNewswire
News headline image
Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
From World Street Intelligence
Via GlobeNewswire
News headline image
Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire

Frequently Asked Questions

Is Smith & Nephew SNATS, Inc. Common Stock publicly traded?
Yes, Smith & Nephew SNATS, Inc. Common Stock is publicly traded.
What exchange does Smith & Nephew SNATS, Inc. Common Stock trade on?
Smith & Nephew SNATS, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Smith & Nephew SNATS, Inc. Common Stock?
The ticker symbol for Smith & Nephew SNATS, Inc. Common Stock is SNN on the New York Stock Exchange
What is the current price of Smith & Nephew SNATS, Inc. Common Stock?
The current price of Smith & Nephew SNATS, Inc. Common Stock is 28.00
When was Smith & Nephew SNATS, Inc. Common Stock last traded?
The last trade of Smith & Nephew SNATS, Inc. Common Stock was at 09/16/26 01:27 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.